Yale study shows immunotherapy drug helps patients with metastatic melanoma

New research suggests that melanoma patients with brain metastases should be given a combination of two types of checkpoint inhibitors.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news